Future Top Trends Shaping the Polymerase Chain Reaction (PCR) Market

Future Top Trends Shaping the Polymerase Chain Reaction (PCR) Market

date

Feb 21, 2024

Blog Biotechnology Future Top Trends Shaping the Polymerase Chain Reaction (PCR) Market

What is Polymerase Chain Reaction?

Polymerase Chain Reaction (PCR) is a molecular biology technique developed by Kary B. Mullis in 1983. It serves as a molecular photocopy machine, allowing scientists to amplify and replicate specific DNA sequences in a controlled and efficient manner. It enables the selective and exponential production of a particular segment of DNA in vitro. PCR involves cycles of heating and cooling to denature the DNA, allowing the synthesis of complementary strands by a DNA polymerase enzyme. This process results in the rapid and precise amplification of the target DNA, making PCR a powerful tool in various applications, including genetic research, diagnostics, and forensic analysis. PCR market has experienced remarkable growth in recent years. BCC Research predicts that the global market for polymerase chain reaction (PCR) is expected to reach $12.6 billion by 2028, reflecting a CAGR of 6.7% from 2023 through 2028.

3 Major Steps Involved in PCR

  • Denaturation: DNA is heated to separate the double strands, breaking hydrogen bonds and creating single-stranded templates.
  • Annealing: Temperature is lowered to allow primers to bind to complementary sequences on the single-stranded DNA templates.
  • Extension: DNA polymerase synthesizes new DNA strands by adding nucleotides to the primers, extending the DNA sequence.

Key Drivers Behind the PCR Technology Market

COVID-19 - The COVID-19 pandemic played a pivotal role in accelerating the growth of the PCR technology market. As the virus spread globally, PCR became the gold standard for diagnosing COVID-19 due to its high sensitivity and specificity in detecting viral genetic material. The urgent need for mass testing, contact tracing, and accurate diagnosis led to unprecedented demand for RT-qPCR testing. Laboratories, healthcare facilities, and diagnostic companies worldwide invested heavily in PCR systems, reagents, and consumables to scale testing capacity and meet the rising demand.

Robust Demand in Industrial Applications - The demand for PCR technology in industrial applications is steadily growing due to its versatility and reliability. PCR plays a crucial role in agriculture, food safety, environmental monitoring, and forensics, offering precise and rapid DNA and RNA analysis. PCR ensures the quality and safety of products and environments. 

Growth in Genomic and Biomarker Research - The genomics market is growing rapidly, and its global reach is expanding. This growth can be attributed to growth in genomic research activities, rising numbers of biotech start-up companies, and increasing use of genomics-based products, such as mRNA-based cancer therapies and mRNA vaccines. The growing interest in understanding genetics, studying gene expression, and exploring genetic variations/biomarkers has driven the demand for PCR technology in the research community.

Growing Demand in Clinical Diagnostics - The growing need for molecular diagnostics in oncology, infectious diseases, and genetic testing has led to a heightened adoption of PCR to detect genetic mutations, infectious diseases, and other clinically relevant biomarkers with high precision. The development of portable and point-of-care (PoC) PCR devices enabled rapid and on-site testing. These devices are used in healthcare facilities, field research, and resource-limited settings, further expanding the PCR market in clinical diagnostics.

Polymerase Chain Reaction (PCR) Technologies and Global Markets

The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.

Top Leading Players in PCR Technology Market

  • Hoffmann-La Roche Ltd. - Founded in 1896, Roche is a research-focused healthcare company. It discovers, develops, and provides diagnostic and therapeutic products and services. The company has two core businesses: pharmaceuticals and diagnostics. In the pharmaceutical sector, the company is engaged in the research, development, manufacturing, and marketing of innovative drugs and therapies across various therapeutic areas, including oncology, immunology, infectious diseases, neuroscience, and ophthalmology. In diagnostics, Roche develops and produces a wide range of in vitro diagnostics solutions, including equipment and reagents for medical labs.
  • Thermo Fisher Scientific Inc. - Founded in 1956, Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Products, and Biopharma Services.
  • Becton, Dickinson and Co. (BD) - BD was established in 1897. It is a medical technology company that develops, manufactures, and sells medical devices and supplies, laboratory equipment, instrument systems, and reagents worldwide. The company sells its products in over 190 countries and employs over 75,000 people globally. It has three business divisions: BD Medical, BD Life Sciences, and BD Interventional.

BCC Research Looks at the Future of PCR Market

The global PCR Technology market is poised for substantial growth, with BCC Research estimating a global market size of $12.6 billion by 2028, exhibiting a steady annual growth rate of 6.7% from 2023 to 2028. The U.S. market is also expected to expand, reaching $4.4 billion by 2028, driven by key market drivers such as the impact of COVID-19, continuous technological advancements, increasing demand in clinical diagnostics, growth in genomic and biomarker research, and robust demand in industrial applications. These factors collectively indicate a positive outlook for the PCR Technology market, reflecting its pivotal role in diverse sectors and its potential to address evolving needs in healthcare, research, and industry.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.

    Stay ahead of industry trends, build your market research strategy and more.

    Heena Singh

    Written By Heena Singh

    Heena Singh is a Senior Executive Email Marketer at BCC Research, with a master’s degree in computer applications. She specializes in content creation and data analytics.

    Guiding smart decisions every step of the way

    Guiding smart decisions every step of the way

    We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.

    Contact Us